F
12.99
4.09 (45.96%)
| Penutupan Terdahulu | 8.90 |
| Buka | 12.85 |
| Jumlah Dagangan | 24,674,474 |
| Purata Dagangan (3B) | 670,068 |
| Modal Pasaran | 702,998,528 |
| Harga / Jualan (P/S) | 2.66 |
| Harga / Buku (P/B) | 2.43 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 29 Oct 2025 |
| Margin Keuntungan | -0.64% |
| Margin Operasi (TTM) | -13.00% |
| EPS Cair (TTM) | -0.010 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | -100.00% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 3.55% |
| Nisbah Semasa (MRQ) | 28.71 |
| Aliran Tunai Operasi (OCF TTM) | 7.81 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 4.40 M |
| Pulangan Atas Aset (ROA TTM) | -2.74% |
| Pulangan Atas Ekuiti (ROE TTM) | -0.23% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Menaik | Bercampur |
| Biotechnology (Global) | Menaik | Bercampur | |
| Stok | Fulcrum Therapeutics, Inc. | Menaik | Menaik |
AISkor Stockmoo
-0.8
| Konsensus Penganalisis | 1.5 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | -5.0 |
| Purata Bergerak Teknikal | 0.0 |
| Osilator Teknikal | 0.5 |
| Purata | -0.75 |
|
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Core |
| % Dimiliki oleh Orang Dalam | 1.82% |
| % Dimiliki oleh Institusi | 96.20% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 25.00 (HC Wainwright & Co., 92.46%) | Beli |
| Median | 18.50 (42.42%) | |
| Rendah | 7.00 (B of A Securities, -46.11%) | Jual |
| Purata | 17.17 (32.18%) | |
| Jumlah | 4 Beli, 1 Pegang, 1 Jual | |
| Harga Purata @ Panggilan | 12.78 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| B of A Securities | 09 Dec 2025 | 7.00 (-46.11%) | Jual | 12.99 |
| Cantor Fitzgerald | 08 Dec 2025 | 24.00 (84.76%) | Beli | 12.99 |
| HC Wainwright & Co. | 08 Dec 2025 | 25.00 (92.46%) | Beli | 12.99 |
| 24 Nov 2025 | 18.00 (38.57%) | Beli | 11.74 | |
| Piper Sandler | 08 Dec 2025 | 23.00 (77.06%) | Beli | 12.99 |
| 30 Oct 2025 | 16.00 (23.17%) | Beli | 8.60 | |
| RBC Capital | 08 Dec 2025 | 10.00 (-23.02%) | Pegang | 12.99 |
| 30 Oct 2025 | 7.00 (-46.11%) | Pegang | 8.60 | |
| Truist Securities | 24 Nov 2025 | 14.00 (7.78%) | Beli | 11.74 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |